1 / 18

NIAID Strategic Plan

New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research. NIAID Strategic Plan. Category A, B, and C Priority Pathogens Biology of the Microbe Host Response Diagnostics Vaccines Therapeutics Research Resources Regional Centers of Excellence

eloise
Download Presentation

NIAID Strategic Plan

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research NERCE / BEID www.nerce.med.harvard.edu

  2. NIAID Strategic Plan • Category A, B, and C Priority Pathogens • Biology of the Microbe • Host Response • Diagnostics • Vaccines • Therapeutics • Research Resources • Regional Centers of Excellence • National Biocontainment Laboratories • Regional Biocontainment Laboratories NERCE / BEID www.nerce.med.harvard.edu

  3. NIAID Priority Pathogens NERCE / BEID www.nerce.med.harvard.edu

  4. Academic / Industry Partnership NERCE / BEID www.nerce.med.harvard.edu

  5. New England Regional Center of Excellence • All medical schools in New England contribute to governance and strategic planning • Institutions currently with active major research projects: • Boston University Medical Center • Center for Blood Research • Harvard Medical School • University of Massachusetts – Dartmouth • University of Massachusetts Medical School • Brigham and Woman’s Hospital • Dartmouth Medical School NERCE / BEID www.nerce.med.harvard.edu

  6. NERCE Strategic Plan -NERCE will provide the nation, as quickly and efficiently as possible, with vaccine and therapeutic interventions against infections caused by organisms used as weapons of bioterrorism -NERCE is using a genomics, proteomics, and high-throughput approach to biodefense development

  7. NERCE Components • 6 Research Programs • 5 Developmental Projects Program • 4 Core Laboratories / Programs • 2 Career Development Programs • Emergency Response Plan • Regional and National Governance Committees NERCE / BEID www.nerce.med.harvard.edu

  8. NERCE Research Programs • Multiple Approaches to Blocking Toxin Action • Direct Inhibition of Anthrax Toxin Action John Collier, PI • Direct Blocking of Botulinium Toxin Action Bal Ram Singh, PI • Disruption by Small Molecules of Intracellular Toxin Transport Tomas Kirchhausen, PI • Mechanism(s) of Endocytic Vesicle Membrane Translocation by Diptheria Toxin, Anthrax Toxin, and Botulinium Neurotoxins Jack Murphy, PI NERCE / BEID www.nerce.med.harvard.edu

  9. NERCE Research Programs • Mediators and Inhibitors of Immunity to Yersinia pestis Michael Starnbach and John Goguen, PIs • Microbial Vectors for Antigen Delivery John Mekalanos, David Knipe, and Darren Higgins, PIs • Development of a Conjugate Vaccine for the Prevention of Tularemia Arthur Tzianabos and Dennis Kasper, PIs NERCE / BEID www.nerce.med.harvard.edu

  10. NERCE Research Programs • Discovery of Small Molecules to Block Fusion by Envelope Proteins of Dengue and Ebola Viruses Stephen Harrison, PI • Innate Immunity to Hemorrhagic Fever Viruses Robert Finberg and Douglas Golenbock, PIs NERCE / BEID www.nerce.med.harvard.edu

  11. NERCE Developmental Projects • Studies of the SARS Receptor ACE2 Michael R. Frazan, PI • Structure of Anthrax Spore Polysaccharide Julia Wang, PI • SARS Coronavirus Pathogenesis in African Green Monkeys Keith G. Mansfield, PI • Development of a Multi-gene Subunit-based smallpox vaccine Shan Lu, PI • Novel Ways to Optimize CTL Response to Vaccinia Virus William R. Green, PI NERCE / BEID www.nerce.med.harvard.edu

  12. NERCE Core Laboratories • BSL-3 Animal and Tissue Culture Andrew Onderdonk, PI • Proteomics Leonardo Brizuela, PI Harvard Institute of Proteomics • Small Molecule Screening Steven Lory, PI Institute for Chemistry and Cell Biology • Clinical Studies Raphael Dolin, PI NERCE / BEID www.nerce.med.harvard.edu

  13. Career Development Program Career Development Program RFP Issued October 14 Applications due December 1 Funding Start March 1 NERCE / BEID www.nerce.med.harvard.edu

  14. Emergency Response Plan • Provide facilities and scientific support to first-line responders in the event of a biodefense or naturally occurring biological emergency • Independent local confirmatory testing of a positive test result derived from Project BioWatch • Scientific expert resource • Laboratory testing consulting services, auxiliary sample testing, and sample storage and archiving NERCE / BEID www.nerce.med.harvard.edu

  15. Regional Centers of Excellence • Duke University • Harvard Medical School • New York State Department of Health • University of Chicago • University of Maryland • University of Texas Medical Branch • University of Washington • Washington University in St. Louis NERCE / BEID www.nerce.med.harvard.edu

  16. NBLs and RBLs • National Biocontainment Laboratories • Boston University • University of Texas Medical Branch • Regional Biocontainment Laboratories • Colorado State University • Duke University • Tulane University • University of Alabama at Birmingham • University of Chicago • University of Medicine and Dentistry of New Jersey • University of Missouri • University of Pittsburgh • University of Tennessee

  17. Assembly and Action of Anthrax Toxin NERCE / BEID www.nerce.med.harvard.edu

  18. Screening for chemicals that protect cells from anthrax toxin Cell Viability NERCE / BEID www.nerce.med.harvard.edu

More Related